2017
DOI: 10.1016/j.ejcdt.2016.11.003
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic resonance apparent diffusion coefficient values of the brain in COPD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…COPD-induced neurocognitive dysfunction is an emerging area of research which includes alterations in memory, executive functioning and attention [ 12 14 ], with up to 61% of people with COPD suffering from neurocognitive dysfunction [ 12 , 15 , 16 ]. Moreover, neurocognitive dysfunction is associated with much of the disease burden, healthcare utilisation and costs, as people with neurocognitive dysfunction often lack adherence to therapeutic interventions and medication, which in turn worsen their COPD morbidity, lead to increased hospitalisations and risk of mortality [ 12 , 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…COPD-induced neurocognitive dysfunction is an emerging area of research which includes alterations in memory, executive functioning and attention [ 12 14 ], with up to 61% of people with COPD suffering from neurocognitive dysfunction [ 12 , 15 , 16 ]. Moreover, neurocognitive dysfunction is associated with much of the disease burden, healthcare utilisation and costs, as people with neurocognitive dysfunction often lack adherence to therapeutic interventions and medication, which in turn worsen their COPD morbidity, lead to increased hospitalisations and risk of mortality [ 12 , 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…COPD-induced neurocognitive dysfunction is an emerging area of research which includes alterations in memory, executive functioning and attention [12][13][14], with up to 61% of people with COPD suffering from neurocognitive dysfunction [12,15,16]. Moreover, neurocognitive dysfunction is associated with much of the disease burden, healthcare utilization and costs, as people with neurocognitive dysfunction often lack adherence to therapeutic interventions and medication, which in turn worsen their COPD morbidity, lead to increased hospitalizations and risk of mortality [12,17].…”
Section: Introductionmentioning
confidence: 99%